Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells.

3D scaffolds decellularization thymic epithelial cells thymus engineering

Journal

Advanced functional materials
ISSN: 1616-301X
Titre abrégé: Adv Funct Mater
Pays: Germany
ID NLM: 101190390

Informations de publication

Date de publication:
17 May 2021
Historique:
received: 14 12 2020
revised: 28 01 2021
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: ppublish

Résumé

The thymus provides the physiological microenvironment critical for the development of T lymphocytes, the cells that orchestrate the adaptive immune system to generate an antigen-specific response. A diverse population of stroma cells provides surface-bound and soluble molecules that orchestrate the intrathymic maturation and selection of developing T cells. Forming an intricate 3D architecture, thymic epithelial cells (TEC) represent the most abundant and important constituent of the thymic stroma. Effective models for in and ex vivo use of adult TEC are still wanting, limiting the engineering of functional thymic organoids and the understanding of the development of a competent immune system. Here a 3D scaffold is developed based on decellularized thymic tissue capable of supporting in vitro and in vivo thymopoiesis by both fetal and adult TEC. For the first time, direct evidences of feasibility for sustained graft-resident T-cell development using adult TEC as input are provided. Moreover, the scaffold supports prolonged in vitro culture of adult TEC, with a retained expression of the master regulator Foxn1. The success of engineering a thymic scaffold that sustains adult TEC function provides unprecedented opportunities to investigate thymus development and physiology and to design and implement novel strategies for thymus replacement therapies.

Identifiants

pubmed: 34539304
doi: 10.1002/adfm.202010747
pii: ADFM202010747
pmc: PMC8436951
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2010747

Informations de copyright

© 2021 The Authors. Advanced Functional Materials published by Wiley‐VCH GmbH.

Déclaration de conflit d'intérêts

Philipp Oertle is a shareholder in ARTIDIS AG. Gitika Srivastava and Philipp Oertle are employed by ARTIDIS AG. The other authors declare no conflict of interest.

Références

Stem Cells Transl Med. 2019 Oct;8(10):1107-1122
pubmed: 31140762
Nat Rev Mater. 2019 Jun;4(6):355-378
pubmed: 31903226
Biotechnol Bioeng. 2003 Oct 20;84(2):205-14
pubmed: 12966577
Trends Immunol. 2016 Dec;37(12):866-876
pubmed: 27720177
FEBS J. 2015 Dec;282(23):4466-79
pubmed: 26299746
Cell Rep. 2014 Aug 21;8(4):1198-209
pubmed: 25131206
Annu Rev Immunol. 2017 Apr 26;35:85-118
pubmed: 28226225
Int Immunol. 1993 Sep;5(9):1139-50
pubmed: 7902130
J Immunol. 2013 Feb 1;190(3):1085-93
pubmed: 23269248
J Histochem Cytochem. 1991 Nov;39(11):1539-46
pubmed: 1918928
Cell Immunol. 2008;254(1):1-9
pubmed: 18644586
Blood. 2006 Dec 1;108(12):3777-85
pubmed: 16896157
EBioMedicine. 2018 Jan;27:258-274
pubmed: 29269042
Eur J Immunol. 2015 Jun;45(6):1760-71
pubmed: 25752506
Nat Immunol. 2016 Oct;17(10):1206-1215
pubmed: 27548434
Exp Eye Res. 2013 Nov;116:298-307
pubmed: 24095823
Clin Immunol. 2018 Nov;196:59-63
pubmed: 29654845
Nature. 2018 Jul;559(7715):622-626
pubmed: 30022162
Nat Commun. 2013;4:2842
pubmed: 24280864
J Immunol. 2006 Jan 15;176(2):730-4
pubmed: 16393955
J Immunol. 2015 Aug 15;195(4):1351-7
pubmed: 26254267
Nat Med. 2021 Jan;27(1):125-135
pubmed: 33432170
Front Immunol. 2018 Mar 19;9:547
pubmed: 29616038
Mol Immunol. 2008 Jan;45(1):25-33
pubmed: 17599412
Nat Mater. 2018 Jun;17(6):484-498
pubmed: 29784994
J Immunol. 1988 May 15;140(10):3373-9
pubmed: 2452185
Nat Immunol. 2010 Aug;11(8):666-73
pubmed: 20644572
Nat Rev Immunol. 2011 May 27;11(7):489-95
pubmed: 21617694
Nat Rev Immunol. 2017 May;17(5):295-305
pubmed: 28317923
Nat Commun. 2017 Oct 13;8(1):924
pubmed: 29030636
Semin Immunopathol. 2008 Dec;30(4):439-56
pubmed: 18974988
Curr Stem Cell Rep. 2016 Jun;2(2):128-139
pubmed: 27529056
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2839-49
pubmed: 27233032
J Immunol. 1992 Mar 15;148(6):1620-9
pubmed: 1347303
Semin Immunol. 1999 Feb;11(1):3-12
pubmed: 9950748
Blood. 2001 Sep 1;98(5):1601-6
pubmed: 11520813
J Comp Pathol. 2010 Jan;142 Suppl 1:S39-44
pubmed: 19897208
Biophys J. 2010 Jun 2;98(11):2731-40
pubmed: 20513418
Dev Comp Immunol. 1998 May-Jun;22(3):367-77
pubmed: 9700465
Adv Funct Mater. 2020 Nov 25;30(48):
pubmed: 33692664
Clin Immunol. 2015 Sep;160(1):82-9
pubmed: 25805654
Nat Nanotechnol. 2012 Nov;7(11):757-65
pubmed: 23085644
Semin Immunol. 2007 Oct;19(5):318-30
pubmed: 18023361
Biomaterials. 2011 Apr;32(12):3233-43
pubmed: 21296410
Nat Biotechnol. 2000 Jul;18(7):729-34
pubmed: 10888839
Biomaterials. 2017 Feb;118:1-15
pubmed: 27940379
Nat Rev Immunol. 2020 Apr;20(4):239-253
pubmed: 31804611
J Struct Biol. 2011 Jun;174(3):476-84
pubmed: 21426942
Mol Ther. 2015 Jul;23(7):1262-1277
pubmed: 25903472
Nature. 2018 Jul;559(7715):627-631
pubmed: 30022164
Immunity. 2005 Mar;22(3):329-41
pubmed: 15780990

Auteurs

M Adelaide Asnaghi (MA)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.

Thomas Barthlott (T)

Department of Biomedicine University Children's Hospital University of Basel Basel 4058 Switzerland.

Fabiana Gullotta (F)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.

Valentina Strusi (V)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.

Anna Amovilli (A)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.

Katrin Hafen (K)

Department of Biomedicine University Children's Hospital University of Basel Basel 4058 Switzerland.

Gitika Srivastava (G)

ARTIDIS AG Basel 4057 Switzerland.

Philipp Oertle (P)

ARTIDIS AG Basel 4057 Switzerland.
Biozentrum and the Swiss Nanoscience Institute University of Basel Basel 4056 Switzerland.

Roberto Toni (R)

Department of Medicine and Surgery - DIMEC, Unit of Biomedical Biotechnological and Translational Sciences (S.BI.BI.T.) Laboratory of Regenerative Morphology and Bioartificial Structures (Re.Mo.Bio.S.) University of Parma Parma 43121 Italy.
Division of Endocrinology Diabetes, and Metabolism Tufts Medical Center - Tufts University School of Medicine Boston MA 02111 USA.

David Wendt (D)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.

Georg A Holländer (GA)

Department of Biomedicine University Children's Hospital University of Basel Basel 4058 Switzerland.
Developmental Immunology Department of Paediatrics and Weatherall Institute of Molecular Medicine University of Oxford Oxford OX3 9DS UK.

Ivan Martin (I)

Department of Biomedicine University Hospital Basel University of Basel Basel 4031 Switzerland.
Department of Biomedical Engineering University Hospital Basel University of Basel Allschwil 4123 Switzerland.

Classifications MeSH